24-Hour Picks Entry: close of 2026-06-10 — Exit: close of 2026-06-12
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| LONG VERU Researched | Veru Inc. | Novo Nordisk clinical supply agreement for enobosarm+Wegovy Phase 2b PLATEAU obesity combo study announced Jun 4. Stock ran $2 to $4.23 on 89.8M vol but still well below Canaccord $25 PT. Major catalyst still being digested. | 8 | $2.95 | $3.00 | $3.34 | ▲ +1.69% |
| SHORT AMC Researched | AMC Entertainment Holdings | Pumped today on no news ($2.29 close) then fading -2.2% AH to $2.24. Dead cat bounce setup — $4.5B debt, relentless dilution, negative EPS. Expects gap down/reversal as shorts reload after today's momentum exhaustion. | 7 | $2.08 | $2.34 | $2.05 | ▼ -12.50% |
24-Hour Picks Entry: close of 2026-06-10 — Exit: close of 2026-06-12
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| LONG GDX Researched | VanEck Gold Miners ETF | DXY at 52-wk low ~99 (-4% YTD) supports gold; Fed Gov Barr speech Fri noon could reinforce dovish tone before Jun 16-17 FOMC; gold $4,477 support backed by central bank buying. Target: GDX tracks gold to $4,600+ | 7 | $73.81 | $80.03 | $80.65 | ▲ +8.43% |
| LONG SLV Researched | iShares Silver Trust | Same DXY tailwind (~99) bullish for silver; dual monetary safe-haven + industrial demand (solar/AI); positioning ahead of FOMC blackout starting Sat. Target: retest $80/oz | 6 | $57.66 | $61.29 | $61.83 | ▲ +6.30% |